(Q37763182)

22 August 2017

Colorectal cancer: current care, future innovations and economic considerations (English)

1 reference

22 August 2017

1 reference

1 reference

David A L Macafee

1

1 reference

PubMed ID

20528555

22 August 2017

Elizabeth H Gemmill

series ordinal

2

1 reference

PubMed ID

20528555

22 August 2017

John N Lund

series ordinal

3

1 reference

22 August 2017

1 April 2006

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

195-206

1 reference

22 August 2017

2

1 reference

British cancer death rates fell by 12% between 1972 and 2002.

22 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

The colorectal adenoma-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Major colorectal cancer resection should not be denied to the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Multidisciplinary case teams: an approach to the future management of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Surgical resection of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Recent aspects of palliative treatment of metastasized colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Aspirin, NSAIDs and colorectal cancer--what do the epidemiological studies show and what do they tell us about the modus operandi?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

American Cancer Society guidelines for the early detection of cancer, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Cost of quality management and information provision for screening: colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Use of multidetector-row CT colonography for detection of colorectal neoplasia in patients referred via the Department of Health "2-Week-wait" initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Screening and the costs of treating colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Patient perceptions of stool-based DNA testing for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Attitudes toward colorectal cancer screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Use of proteomic patterns to screen for gastrointestinal malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Noninvasive testing for colorectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Cardiovascular effects at multi-detector row CT colonography compared with those at conventional endoscopy of the colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

A prospective single centre study comparing computed tomography pneumocolon against colonoscopy in the detection of colorectal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Current and future trends in colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Is computed tomographic colonography effective for colorectal cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Multimodal strategies to improve surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Rectal cancer: the role of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Adjuvant chemotherapy in colon cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Pharmacogenetics of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

First-line treatment options for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Metastatic colorectal cancer: treatment challenges and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Guidelines for follow up after resection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Demography. Broken limits to life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Cancer care in the United Kingdom: new solutions are needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Costs of palliative care in the community, in hospitals and in hospices in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

Systematic Follow-up After Curative Surgery for Colorectal Cancer in Norway: A Population-Based Audit of Effectiveness, Costs, and Compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.2.195

21 January 2018

Identifiers

DOI

10.1586/14737167.6.2.195

1 reference

22 August 2017

1 reference

PubMed ID

20528555